Rimantadine Hydrochloride

็›้…ธ้‡‘ๅˆšไน™่ƒบ

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameRimantadine Hydrochloride
Drug Alias Namerimantadina้‡‘ๅˆšไน™่ƒบ็›้…ธ็›rimantadinum็›้…ธ้‡‘ๅˆšไน™็ƒท้‡‘ๅˆš็ƒทไน™่ƒบ +[12]ย 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix protein 2 inhibitors
TargetsMatrix protein 2
Therapy Area/IndicationsInfluenza A virus infectionsInfluenza, Human
Global Approved IndicationsInfluenza A virus infectionsInfluenza, Human
Approved Indications in ChinaInfluenza A virus infections
Original Approved Country/TerritoryUnited States
Original Approved Date1993/09/17
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Active IndicationsInfluenza A virus infections
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeJ05AC02